Commercial Potential. Launch Strategy. Commercial Analytics.Sentero Pharma is a life sciences consulting firm delivering customized commercial solutions to clients in development-stage through launch and beyond. We've supported products targeting populations from under 100 patients to over 1,000,000, including gene therapy and oncology indications. Our partners are former senior leaders in biopharma companies, and our extensive experience guides how we execute projects, from commercial assessments for early-stage candidates to launch strategy and pull through for those further down the pathway to post-launch commercial analytics for newly launched or established products. Whether as a defined-scope contracted strategic partner or as an ongoing embedded commercial team member, we’ll approach your business with the same curiosity, rigor and care as we have our own, helping you confidently answer tough questions and make informed decisions.Portfolio of Services:Commercial Potential: Fit-for-purpose assessment based on client’s stage of development• Market Size and Structure• Competitive Positioning• Payer Access and Pricing • Market Share and ForecastLaunch Strategy & Pull Through: Execute commercial planning imperatives during clinical development and regulatory review phases• End-to-End Launch Roadmap• Customer Identification and Development• Operational Planning• Commercial SG&A Planning• Systems and TechnologyPost-Launch Analytics: Ongoing tracking and performance improvement for marketed products• Performance Tracking• Operational EffectivenessMarket Insights: Subscribed market intelligence and search access; primary market research capabilities• Competitive Intelligence• Primary Market ResearchWe'd welcome the opportunity to share more about how we can be helpful from development-stage through launch and beyond. email us at info@senteropharma.com or visit our website: https://www.senteropharma.com/

Specialty pharmaceutical company marketing prescription drugs through dedicated sales teams ranging from 60 to 335. Leadership and accountability for teams in all commercial functional areas, including product launches, marketing, sales, market access, distribution, and business development. Helped guide commercial organization through acquisition and launch of NDA-stage orphan specialty injectable drug. Required remediation of complete response letter and NDA resubmission prior to marketing approval. Responsible for negotiating, contracting and operational implementation of dedicated HUB-based patient care center and affiliated non-retail distribution network consisting of five specialty distributors and 12 specialty pharmacies.Led relaunch of two legacy products following resolution of obligations associated with consent decree, including: contract manufacturing coordination; wholesale/retail stocking; pre-launch market research; marketing and sales strategy; sales training; launch meeting. Managed national sales director and area sales directors whose teams included 15 district sales managers and 150 sales representatives; provided coaching and direction related to sales performance and human resource issues. Led engagement with external compliance vendor; designed and implemented comprehensive project including baseline compliance assessment, gap analysis and creation of compliance roadmap for commercial organization.

Commercial leader for organization in high growth period during which annual net revenues grew from $25MM to $215MM. Achieved balanced revenue across 3 therapeutic franchises with each ranging in contribution from 25% to 40% of total net revenues.Designed organizational structure and implemented several phases of expansion; implemented wide-ranging improvements in business practices resulting in significantly enhanced organizational effectiveness. Launched five new brands into new and established markets. Brands launched into established markets significantly outperformed their respective markets; average annual volume growth in the first five years after launch ranged from 19% to 45% in relatively flat markets.Responsible for conducting commercial assessments and providing strategic recommendations on pipeline and acquisition candidates. Evaluated dozens of opportunities; company executed five acquisitions with aggregate deal values of $380MM.Managed team of six account directors with responsibility for ensuring market access to company’s portfolio of products in commercial and government payers.Managed all external partner relationships including vetting, contracting and performance/ budget management. Partners included creative and public relations agencies, market research firms, audited data service providers, government pricing and commercial compliance consultants.

Sole responsibility for all operational aspects of product marketing and support of sales teams.Authored annual brand plans/expense budgets and presented for management approval; planned and implemented all tactics; presented plans to sales management and field organization. Planned and orchestrated regional and national sales meetings. Conducted multiple sales force size and structure analyses and implemented optimized sales force deployments.Executed rebranding of primary promoted products, including: creative agency RFP process; pitch coordination and agency transition; primary market research including positioning, messaging and creative concepts; introduction to sales organization.